Navigation Links
J & J's DePuy Hip Division in $4Bil Settlement, Says Legal-Bay
Date:11/14/2013

NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, is reporting -via Bloomberg News- that a landmark settlement has been reached in the extensive DePuy ASR Hip Implant Litigation.  According to sources, the total settlement is approximately $4Bil, which makes it the largest medical device settlement in U.S. history. 

(Logo: http://photos.prnewswire.com/prnh/20131114/PH16982LOGO)

Back in September, Legal-Bay had reported that a settlement of $3Bil was on the horizon, and the average case value for a DePuy Hip requiring revision surgery would be around $300K; it looks as if these figures are pretty accurate.  However, neither side is confirming the details of the reports just yet. 

Legal-Bay has been assisting so many victims of the defective DePuy hip implant device since the start of the litigation in 2010, by providing them with lawsuit pre-settlement funding up to $50,000.00 on their cases.  Legal-Bay will continue to provide lawsuit cash advances, not lawsuit loans, on pending and proposed settled DePuy cases.  To learn more about Legal-Bay's DePuy settlement cash advance program, which is not a settlement loan, you can log on to Legal-Bay's website at: http://lawsuitssettlementfunding.com/depuy-hip-recall-settlement-funding.php

Chris Janish, CEO of Legal-Bay commented, "We always believed that this litigation was one in which J&J would have to step up to the plate, and it seems they now have, with this historic settlement.  The plaintiff's lawyers did a tremendous job getting the company to agree to such a large number now; and to leave the litigation uncapped as more patient's hips fail in the upcoming years.  Most importantly our long suffering clients can now get some of the relief they have long awaited for."  Actual payments do not expect to be disbursed until mid-2014, according to Legal-Bay, if the Judge approves the settlement. 

If you are in need of settlement funding on your DePuy case or in need of speaking to a lawyer about filing a claim on either your DePuy ASR or Pinnacle hip implant, feel free to call Legal-Bay directly at: 877.571.0405 or you may also apply online at: http://lawsuitssettlementfunding.com.

Contact:

Patty Kirby, Head of Client Relations


Ph. 877.571.0405  Email:  info@legal-bay.com       

 


'/>"/>
SOURCE Legal-Bay
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- TapImmune,Inc. (TPIV), a clinical-stage immune-oncology ... immunotherapeutics and vaccines for the treatment of cancer & metastatic ... Annual Growth Capital Expo to be held on May ... Palace in Las Vegas, Nevada.  The Company presentation will ... by Dr. John N. Bonfiglio a TapImmune ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... It has just been announced ... for five events throughout the month of May. , Uldrich is the author of ... outlets. He also frequently appears on the Science Channel’s FutureScape and Discovery Channel’s Inside ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... Issue 1 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... With almost half the issue representing international (non-US) based authors, the third volume ...
(Date:5/2/2016)... ... 02, 2016 , ... Beanfields, PBC, makers of Beanfields Bean ... students at University of Colorado in Boulder to create new advertising campaigns. , ... the School of Journalism, who selected Beanfields as the brand on which to ...
(Date:5/2/2016)... ... 2016 , ... Amica Life Insurance Company has unveiled ... various life stages. , The site launched on April 1, and it has ... to the times when life insurance matters most. , “Through our research, we ...
(Date:5/2/2016)... ... 2016 , ... The National Resident Matching Program® (NRMP®) has ... Match”), the system through which U.S. and international medical school students and graduates ... placed in the 2016 Match, and 29,572 were filled when the matching algorithm ...
Breaking Medicine News(10 mins):